Second Sight Medical Products (EYES) Financials

$28.55

$24.41 (589.64%)

As on 15-Sep-2026 12:09EDT

Market cap

$54 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

0.9

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Operating Revenue	0.00	0.00	0.00	3.38	6.90	7.96
Cost of Revenue	0.00	0.00	-0.50	2.15	4.89	5.12
Gross Profit	0.00	0.00	0.50	1.23	2.01	2.85
Operating Expenses	0.01	0.01	13.17	31.82	36.63	31.46
Operating Profit (EBIT)	-2.52	-0.01	-14.90	-33.95	-35.18	-28.61
Other Income	0.00	--	0.02	0.36	0.09	0.09
Profit before Tax	-2.52	-0.01	-14.88	-33.59	-35.09	-28.52
Provision for Tax	--	--	--	--	--	--
Profit after Tax (Net Income)	-2.52	-0.01	-14.88	-33.59	-35.09	-28.52
Minority Interest	--	--	--	--	--	--
Consolidated Profit	-9.07	-8.92	-14.88	-33.59	-35.09	-28.52

Liabilities ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Shareholder's Funds	63.06	68.37	-0.67	7.28	3.08	7.88
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	0.05	--	2.37	--	--
Current Liabilities	2.59	2.46	5.13	6.96	7.60	6.62
Total Liabilities	68.24	70.88	4.46	16.60	10.68	14.50

Assets ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Non-Current Assets	8.26	0.37	0.19	3.49	1.06	1.33
Current Assets	57.39	70.51	4.27	13.11	9.62	13.17
Total Assets	68.24	70.88	4.46	16.60	10.68	14.50
Total Debt*	0.15	0.24	2.20	2.60	--	--
Net Current Assets	54.80	68.05	-0.86	6.15	2.02	6.55

Cashflow ($ Mln)	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Cash From Operating Activities	--	-9.19	-16.82	-27.63	-29.81	-23.95
Cash Flow from Investing Activities	--	-0.01	0.07	-0.49	-0.16	-0.27
Cash from Financing Activities	--	75.62	8.60	34.99	26.60	21.17
Net Cash Inflow / Outflow	--	--	-8.15	6.86	-3.37	0.07

Financials Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Adjusted EPS ($)	--	--	--	--	--	--
Cash EPS ($)	--	--	--	--	--	--
Adjusted Book Value ($)	--	--	--	--	--	--
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	--	--	--	--	--
Free Cash Flow per Share ($)	--	--	--	--	--	--

Profitability Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
ROCE (%)	--	-0.03	-260.94	-518.36	-640.05	-299.70
ROE (%)	-3.83	-0.03	-450.70	-648.56	-640.05	-299.70
ROA (%)	-3.40	-0.02	-141.32	-246.27	-278.76	-182.17
EBIT Margin (%)	-980,090.38	-3,431.15	-1,488,000.00	-994.14	-508.90	-358.06
Net Margin (%)	-59,042.46	-3,431.15	-87,529.41	-897.94	-502.64	-353.93
Cash Profit Margin (%)	-15.60	--	--	--	--	--

Growth Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Revenue Growth (%)	--	-0.74	-1.00	-0.51	-0.13	1.00
EBIT Growth (%)	68.27	99.94	55.70	4.28	-23.07	14.05
Net Profit Growth (%)	68.68	99.94	55.70	4.28	-23.07	14.05
EPS Growth (%)	--	--	--	--	--	--
Book Value Growth (%)	--	--	--	--	--	--

Valuation Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Price / Earnings	--	--	--	--	--	--
Price / Book Value	0.86	--	--	--	--	--
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	0.20	-1,135.51	0.07	0.26	0.13	0.28
Close Price ($)	6.09	4.89	5.61	17.81	21.25	45.84
High Price ($)	15.84	60.00	19.20	28.80	61.92	67.92
Low Price ($)	3.42	4.20	2.07	15.36	15.24	21.60
Market Cap ($ Cr)	54.38	--	--	--	--	--

Solvency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debt to Equity	--	0.00	-3.27	0.36	--	--
Short term debt to equity ratio	0.00	0.00	-3.27	0.03	--	--
Current Ratio	22.15	28.64	0.83	1.88	1.27	1.99
Quick Ratio	22.15	--	0.83	1.74	0.84	1.58
Interest Coverage	--	--	--	--	--	--

Operating Efficiency Ratios	TTM	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16	Dec-15	Dec-14	Dec-13	Dec-12
Debtors to sales (%)	--	115,384.62	--	13.47	7.31	22.99
Asset Turnover	0.00	0.00	0.00	0.25	0.55	0.51
Receivable days	--	421,442.31	166,188.75	51.83	61.84	48.27
Inventory Days	--	--	-375.84	363.13	222.30	218.28
Payable days	--	1,411,831.73	-576.73	203.50	76.85	68.10
Cash Conversion Cycle	--	-990,389.42	166,389.64	211.46	207.29	198.45

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.